title: Reply To the Editor, Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315.
authors.affiliation: Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege University, Turkey.
authors.forename: Derya Hopanci
authors.initials: DH
authors.lastname: Bicakli
authors.affiliation: Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege University, Turkey varolumut@yahoo.com.
authors.forename: Umut
authors.initials: U
authors.lastname: Varol
authors.affiliation: Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege University, Turkey.
authors.forename: Mustafa
authors.initials: M
authors.lastname: Degirmenci
authors.affiliation: Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege University, Turkey.
authors.forename: Didem
authors.initials: D
authors.lastname: Tunali
authors.affiliation: Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege University, Turkey.
authors.forename: Burcu
authors.initials: B
authors.lastname: Cakar
authors.affiliation: Department of Public Health, School of Medicine, Ege University, Turkey.
authors.forename: Raika
authors.initials: R
authors.lastname: Durusoy
authors.affiliation: Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege University, Turkey.
authors.forename: Burcak
authors.initials: B
authors.lastname: Karaca
authors.affiliation: Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege University, Turkey.
authors.forename: Ulus Ali
authors.initials: UA
authors.lastname: Sanli
authors.affiliation: Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege University, Turkey.
authors.forename: Ruchan
authors.initials: R
authors.lastname: Uslu
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects*; D005260:Female; D006801:Humans; D024821:Metabolic Syndrome / Q000139:chemically induced* / Q000175:diagnosis*